Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002005
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
A Phase I Study of Recombinant CD4rCD4 in Patients With AIDS and AIDS-Related Complex
Sponsor:
Genentech Inc
Organization:
NIH AIDS Clinical Trials Information Service
Study Overview
Official Title:
A Phase I Study of Recombinant CD4rCD4 in Patients With AIDS and AIDS-Related Complex
Status:
COMPLETED
Status Verified Date:
1990-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine the safety profile and maximum tolerated dose MTD of recombinant soluble human CD4 rCD4 therapy in patients with AIDS or AIDS related complex ARC To obtain a preliminary indication of the antiviral effects of rCD4 in patients with AIDS and ARC To measure steady state serum levels of rCD4 following continuous infusion therapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| Serial Number 002 | None | None | None |
| CO036g | None | None | None |